OncoMark attended the European Society of Medical Oncology (ESMO) 2017 Congress
OncoMark attended the European Society of Medical Oncology 2017 Congress in Madrid, Spain, from the 8th-12th September. Mr. Des O’Leary (CEO), Prof. Liam Gallagher (CSO), and Mr. Stephen Barron (Senior Biostatistician) attended this Congress and presented a poster entitled “OncoMasTR: Prognostic Value of Master Transcriptional Regulators (MTRs) in Early Stage Breast Cancer”. The poster presentation was held on Monday 11th September, with a dedicated viewing from 13:15-14:15.
The team had a number of visitors who wanted to engage and hear more about OncoMasTR including:
- Scientific and clinical research groups who share our vision to improve cancer outcomes by developing highly accurate tests that deliver value to patients and clinicians
- Technology companies to partner on the development and commercialisation of OncoMasTR
- Distribution / Clinical Laboratories to partner to make this high value test available to a global customer base.
Contact details during ESMO: Phone 00353-(0)87-7503333 & firstname.lastname@example.org.